Key facts
- Notable investors include Dean & Dean Capital Group Corporation.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Cannava
- ·The full record, as it builds
Funding rounds
No funding rounds for Cannava are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cannava
Operator of a medical cannabis company intended to produce pharmaceutical-grade medicinal cannabis for clients. The company is engaged in developing the entire production process from seed to plant cultivation, implementing various cultivation strategies and incorporating technology into the process.
- Sector
- Healthcare
- HQ
- Jujuy, Argentina
- Founded
- 2018
- Employees
- 52
- Website
- cannava.com.ar/
- Ownership
- Privately Held (backing)
Cannava doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cannava shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cannava in its N-PORT filings yet. We sweep new filings monthly.